|
End-of-day quote
Korea S.E.
2026-09-14
|
5-day change | 1st Jan Change | ||
| 3,175.00 KRW | -2.31% |
|
-7.57% | -53.85% |
| 04-13 | Genome & Company announced that it has received KRW 6.99999414 billion in funding | CI |
| 04-02 | Genome & Company announced that it expects to receive KRW 6.99999414 billion in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 127M | - | - | - | - | - |
| 45.48B | |||||
| 43.68B | - | - | - | - | - |
| 43.09B | |||||
| 39.4B | |||||
| 31.91B |
Select your edition
All financial news and data tailored to specific country editions
